obstruct 发表于 2025-3-23 13:01:22

http://reply.papertrans.cn/3/208/20789/20789-11.png

adroit 发表于 2025-3-23 15:04:59

http://reply.papertrans.cn/3/208/20789/20789-12.png

STEER 发表于 2025-3-23 20:13:44

http://reply.papertrans.cn/3/208/20789/20789-13.png

奇思怪想 发表于 2025-3-23 23:51:59

http://reply.papertrans.cn/3/208/20789/20789-14.png

HAUNT 发表于 2025-3-24 05:04:10

Submitted on: 02 August 2009.
Revised on: 11 August 2009.
Accepted on: 26 August 2009.
LEPROSY REVIEW

熟练 发表于 2025-3-24 10:01:25

http://reply.papertrans.cn/3/208/20789/20789-16.png

ACRID 发表于 2025-3-24 11:09:57

Submitted on: 09 June 2013.
Revised on: 23 June 2013.
Accepted on: 11 July 2013.
LEPROSY REVIEW

plasma 发表于 2025-3-24 15:13:33

http://reply.papertrans.cn/3/208/20789/20789-18.png

Biomarker 发表于 2025-3-24 22:45:15

Submitted on: 12 July 2005.
Revised on: 13 August 2005.
Accepted on: 28 August 2005.
LEPROSY REVIEW---LEPRA

尽责 发表于 2025-3-24 23:18:24

Submitted on: 20 May 2016.
Revised on: 11 June 2016.
Accepted on: 06 July 2016.
LEPROSY REVIEW
页: 1 [2] 3 4
查看完整版本: SCIE期刊LEPROSY REVIEW 2024/2025影响因子:0.839 (LEPROSY REV) (0305-7518). (INFECTIOUS DISEASES)(传染病)Science Citation Index Ex